Abstract
Non-small cell lung cancer (NSCLC) patients greatly benefit from the treatment with tyrosine kinase inhibitors (TKIs) targeting the epidermal growth f......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
